OVID Insider Trading Activity and SEC Form 4 Filings
OVID insider trading summary
Over the past 12 months, insiders at Ovid Therapeutics Inc. (OVID) reported 2 sales worth $29K by 2 insiders and no open-market purchases on SEC Form 4. Net insider selling was $29K.
Latest OVID insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Feb 23, 2026 | Jeffrey A Rona | Cbfo | Sell | $12K (8,541 @ $1.45) |
| Feb 23, 2026 | Margaret A. Alexander | President and CEO | Sell | $17K (11,656 @ $1.45) |
| Feb 26, 2025 | Jeffrey A Rona | Cbfo | Sell | $2K (3,902 @ $0.56) |
| Feb 26, 2025 | Margaret A. Alexander | President and COO | Sell | $3K (5,279 @ $0.56) |
| Jan 27, 2025 | Margaret A. Alexander | President and COO | Buy | $5K (6,810 @ $0.73) |
| Mar 18, 2024 | Jeremy M Levin | CEO | Buy | $50K (18,248 @ $2.76) |
| Sep 12, 2022 | Jason Tardio | Chief Operating Officer | Sell | $37K (17,344 @ $2.15) |
| Jul 14, 2021 | Amit Rakhit | President and CMO | Sell | $126K (34,017 @ $3.71) |
| Aug 28, 2020 | Jeremy M Levin | CEO | Buy | $50K (8,488 @ $5.84) |
| Oct 8, 2019 | Jeremy M Levin | CEO | Buy | $150K (60,000 @ $2.50) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.